RESULTS OF OPEN MULTICENTER STUDY OF THE SAFETY OF DOXAZOSIN IN COMBINATION WITH INDIGAL IN MEN WTTH STAGES I-II PROSTATIC ADENOMA

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents a method of conservative treatment of men with I-II stage prostatic; adenoma using a combination of doxazosin and indigal, whiah Llels antioxidant, antiproliferative and anti-inflammatory properties, that allowed improving urodynamic parameters and reducing the progression prostate adenoma, minimizing the adverse effects of treatment.

Full Text

Restricted Access

References

  1. Gupta S., Hussain T., Mukhtar H. Molecular pathway for (-)-epigaUocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells, Arch. Biochem. Biophys. 2003;410(1):177—185.
  2. Kondo T., Ohta T., Igura K. et al. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. 2002;180(2):139-144.
  3. Fujimoto N., Sueoka N., Sueoka E. et al. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1, Int. J. Oncol. 2002;20:1233-1239.
  4. Ahmad N., Feyes D.K., Nieminen A.L. et al. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells, J. Natl. Cancer Inst. 1997;89:1881-1886.
  5. Masuda M., Suzuki M., Lim J.T.E. et al. Epigallocatechin-3-gallate Inhibits Activation of HER-2/neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells. Clin. Cancer Res. 2003;9:3486-3491.
  6. Zhang J., Hsu B.A.J, Kinseth B.A.M. et al. Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in hum an LNCaP prostate carcinoma cells. Cancer. 2003;98:2511-2520.
  7. Riby J.E., Firestone G.L, Bjeldcmec L.F. 3,3’-diindolylmethane reduces levels of HIF-1alpha and HIF-1 activity in hypoxic cultured human cancer cells. Biochem. Pharmacol. 2008;75(9):1858-1867.
  8. Sah J.F., Balasubramanian S., Eckert R.L. et al. Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling Pathway. J. Biol. Chem. 2004;279:12755-12762.
  9. Chinni S.R., Sarkar F.H. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin. Cancer Res. 2002;8:1228-1230.
  10. Sartippour M.R., Shao Z.M., Heber D. et al. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr. 2002;132:2307-2311.
  11. Lamy S., Gingras D., Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 2002;62:381-385.
  12. Bradlow H.L., Sepkovic D. W., Telang N. T. et al. Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent. Ann. NY Acad. Sci. 1999;889:204-213.
  13. Chinni S.R., Li Y., Upadhyay S. et al. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001;20:2927-2936.
  14. Jin L., Qi M., Chen D.Z. et al. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res. 1999;59:3991-3997.
  15. Jung Y.D., Kim M.S., Shin B.A. et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br. J. Cancer. 2001;84:844-850.
  16. Kundu J.K., Na H.K., Chun K.S. et al. Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J. Nutr. 2003; 133(11 Suppl. 1):3 805S-3810.
  17. Le H.T., Schaldach C.M., Bjeldanes L.F. Plant-derived 3,3’-Diin-dolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells. J. Biol. Chem. 2003;278:21136-21145.
  18. Li Y., Li X., Sarkar F.H. Gene expression profiles of I3C- and DIM-treated PC3 human cancer cell line, PC3, by 3,3’-diindolylmethane through the mitochondrial pathway. Br. J. Cancer. 2004;91:1358-1363.
  19. McConnell J.D., Roehrborn C.G., Bautista O.M. et al. The long-term effect of doxazosin, Finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N. Engl. J. Med. 2003;349:2387-2398.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies